Page 120 - Read Online

Alipov et al. Difference between native and desialylated LDL

Ethics approval index: a potential novel index for predicting cardiovascular disease.
Vasc Health Risk Manag 2015;11:525-32.
Not applicable. 17. Estruch M, Sánchez-Quesada JL, Ordóñez Llanos J, Benítez S.
Electronegative LDL: a circulating modified LDL with a role in
REFERENCES inflammation. Mediators Inflamm 2013;2013:181324.
18. Chu CS, Wang YC, Lu LS, Walton B, Yilmaz HR, Huang RY,
1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman Sawamura T, Dixon RA, Lai WT, Chen CH, Lu J. Electronegative
M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman low-density lipoprotein increases C-reactive protein expression in
MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth vascular endothelial cells through the LOX-1 receptor. PLoS One
LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, 2013;8:e70533.
Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol 19. Estruch M, Bancells C, Beloki L, Sanchez-Quesada JL, Ordóñez-
G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Llanos J, Benitez S. CD14 and TLR4 mediate cytokine release
Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh promoted by electronegative LDL in monocytes. Atherosclerosis
RW, Turner MB; American Heart Association Statistics Committee 2013;229:356-62.
and Stroke Statistics Subcommittee. Heart disease and stroke 20. Sevanian A, Asatryan L, Ziouzenkova O. Low density lipoprotein
statistics--2015 update: a report from the american heart association. (LDL) modification: basic concepts and relationship to atherosclerosis.
Circulation 2015;131:e29-322. Blood Purif 1999;17:66-78.
2. Aluganti Narasimhulu C, Fernandez-Ruiz I, Selvarajan K, Jiang X, 21. Lee AS, Wang GJ, Chan HC, Chen FY, Chang CM, Yang CY, Lee
Sengupta B, Riad A, Parthasarathy S. Atherosclerosis--do we know YT, Chang KC, Chen CH. Electronegative low-density lipoprotein
enough already to prevent it? Curr Opin Pharmacol 2016;27:92-102. induces cardiomyocyte apoptosis indirectly through endothelial cell-
3. Parhofer KG. Increasing HDL-cholesterol and prevention of released chemokines. Apoptosis 2012;17:1009-18.
atherosclerosis: a critical perspective. Atheroscler Suppl 2015;18:109-11. 22. Chen CY, Hsu HC, Lee AS, Tang D, Chow LP, Yang CY, Chen
4. Ridker PM. LDL cholesterol: controversies and future therapeutic H, Lee YT, Chen CH. The most negatively charged low-density
directions. Lancet 2014;384:607-17. lipoprotein L5 induces stress pathways in vascular endothelial cells. J
5. Ference BA, Yoo W, Alesh I, Mahajan N, Mirowska KK, Mewada Vasc Res 2012;49:329-41.
A, Kahn J, Afonso L, Williams KA Sr, Flack JM. Effect of long-term 23. Mogilenko DA, Kudriavtsev IV, Trulioff AS, Shavva VS, Dizhe EB,
exposure to lower low-density lipoprotein cholesterol beginning early Missyul BV, Zhakhov AV, Ischenko AM, Perevozchikov AP, Orlov
in life on the risk of coronary heart disease: a Mendelian randomization SV. Modified low density lipoprotein stimulates complement C3
analysis. J Am Coll Cardiol 2012;60:2631-9. expression and secretion via liver X receptor and Toll-like receptor 4
6. Soran H, Dent R, Durrington P. Evidence-based goals in LDL-C activation in human macrophages. J Biol Chem 2012;287:5954-68.
reduction. Clin Res Cardiol 2017;106:237-48. 24. Chan HC, Ke LY, Chu CS, Lee AS, Shen MY, Cruz MA, Hsu JF,
7. Rahman A, Ahmed MU, Islam AK, Karim A, Sarker SA. A young Cheng KH, Chan HC, Lu J, Lai WT, Sawamura T, Sheu SH, Yen
male with familial hypercholesterolemia. J Saudi Heart Assoc JH, Chen CH. Highly electronegative LDL from patients with ST-
2012;24:261-4. elevation myocardial infarction triggers platelet activation and
8. Norata GD, Ballantyne CM, Catapano AL. New therapeutic principles aggregation. Blood 2013;122:3632-41.
in dyslipidaemia: focus on LDL and Lp(a) lowering drugs. Eur Heart 25. Kannan Y, Sundaram K, Aluganti Narasimhulu C, Parthasarathy S,
J 2013;34:1783-9. Wewers MD. Oxidatively modified low density lipoprotein (LDL)
9. Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side inhibits TLR2 and TLR4 cytokine responses in human monocytes but
effects. J Am Coll Cardiol 2016;67:2395-410. not in macrophages. J Biol Chem 2012;287:23479-88.
10. Diffenderfer MR, Schaefer EJ. The composition and metabolism of 26. Niccoli G, Bacà M, De Spirito M, Parasassi T, Cosentino N, Greco G,
large and small LDL. Curr Opin Lipidol 2014;25:221-6. Conte M, Montone RA, Arcovito G, Crea F. Impact of electronegative
11. Filipovic I, Schwarzmann G, Mraz W, Wiegandt H, Buddecke E. low-density lipoprotein on angiographic coronary atherosclerotic
Sialic-acid content of low-density lipoproteins controls their binding burden. Atherosclerosis 2012;223:166-70.
and uptake by cultured cells. Eur J Biochem 1979;93:51-5. 27. Hirowatari Y, Homma Y, Yoshizawa J, Homma K. Increase of
12. Tertov VV, Bittolo-Bon G, Sobenin IA, Cazzolato G, Orekhov AN, electronegative-LDL-fraction ratio and IDL-cholesterol in chronic
Avogaro P. Naturally occurring modified low density lipoproteins kidney disease patients with hemodialysis treatment. Lipids Health
are similar if not identical: more electronegative and desialylated Dis 2012;11:111.
lipoprotein subfractions. Exp Mol Pathol 1995;62:166-72. 28. Hsu JF, Chou TC, Lu J, Chen SH, Chen FY, Chen CC, Chen JL,
13. Harada LM, Carvalho MD, Passarelli M, Quintão EC. Lipoprotein Elayda M, Ballantyne CM, Shayani S, Chen CH. Low-density
desialylation simultaneously enhances the cell cholesterol uptake and lipoprotein electronegativity is a novel cardiometabolic risk factor.
impairs the reverse cholesterol transport system: in vitro evidences PLoS One 2014;9:e107340.
utilizing neuraminidase-treated lipoproteins and mouse peritoneal 29. Maranhão RC, Carvalho PO, Strunz CC, Pileggi F. Lipoprotein
macrophages. Atherosclerosis 1998;139:65-75. (a): structure, pathophysiology and clinical implications. Arq Bras
14. Orekhov AN, Bobryshev YV, Sobenin IA, Melnichenko AA, Cardiol 2014;103:76-84.
Chistiakov DA. Modified low density lipoprotein and lipoprotein- 30. Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Li XD, Dotterweich
containing circulating immune complexes as diagnostic and prognostic W, Pollard RB, Asmuth DM, Berglund L. HIV disease activity as a
biomarkers of atherosclerosis and type 1 diabetes macrovascular modulator of lipoprotein(a) and allele-specific apolipoprotein(a)
disease. Int J Mol Sci 2014;15:12807-41. levels. Arterioscler Thromb Vasc Biol 2013;33:387-92.
15. Sánchez-Quesada JL, Villegas S, Ordóñez-Llanos J. Electronegative 31. Helgadottir A, Gretarsdottir S, Thorleifsson G, Holm H, Patel RS,
low-density lipoprotein. A link between apolipoprotein B misfolding, Gudnason T, Jones GT, van Rij AM, Eapen DJ, Baas AF, Tregouet
lipoprotein aggregation and proteoglycan binding. Curr Opin Lipidol DA, Morange PE, Emmerich J, Lindblad B, Gottsäter A, Kiemeny
2012;23:479-86. LA, Lindholt JS, Sakalihasan N, Ferrell RE, Carey DJ, Elmore JR,
16. Ivanova EA, Bobryshev YV, Orekhov AN. LDL electronegativity Tsao PS, Grarup N, Jørgensen T, Witte DR, Hansen T, Pedersen
Vessel Plus ¦ Volume 1 ¦ September 26, 2017 113